# US 2009/0269322 A1 · Compositions comprising selenium-rich yeast and yeast beta-glucan

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0269322 A1
- Document ID: US20090269322A1
- Status: Published application
- Kind: A1
- Application number: 12/264,331
- Filed: 2008-11-04
- Published: 2009-10-29
- Earliest claimed: 2008-04-29
- Assignees: Angel Yeast Co., Ltd.
- Inventors: Xuefeng YU; Zhihong LI; Minghua YU; Juan YAO; Yan ZHANG; Yamin ZHU
- Web page: https://patentgrep.com/patent/US20090269322A1

## CPC

- A23L 33/14: Yeasts or derivatives thereof
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23L 33/15: Vitamins
- A23L 33/16: Inorganic salts, minerals or trace elements
- A61K 36/06: Fungi, e.g. yeasts
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61P 37/04: Immunostimulants
- A61P 39/00: General protective or antinoxious agents
- A61P 39/06: Free radical scavengers or antioxidants
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A nutritional composition comprising by weight: between 0.05 and 30% selenium-enriched yeast; between 1 and 90% yeast beta-glucan; between 0.5 and 60% Vitamin C; and between 0.5 and 40% Vitamin E. The composition features anti-oxidative, anti-aging, cancer-preventing, and immune-stimulating properties.

## Claims

### Claim 1

A nutritional composition having synergistic anti-oxidative properties comprising by weight:
between 0.05 and 30% selenium-enriched yeast;
between 1 and 90% yeast beta-glucan;
between 0.5 and 60% Vitamin C; and
between 0.5 and 40% Vitamin E.

### Claim 2 (depends on 1)

The composition of claim 1 comprising by weight:
between 0.5 and 10% selenium-enriched yeast;
between 20 and 58% yeast beta-glucan;
between 20 and 40% Vitamin C; and
between 20 and 30% Vitamin E.

### Claim 3 (depends on 2)

The composition of claim 2, wherein said selenium-enriched yeast comprises between 500 and 2000 ppm of selenium.

### Claim 4 (depends on 3)

The composition of claim 3, wherein said yeast beta-glucan comprises by weight between 20 and 90% of beta-glucan.

### Claim 5 (depends on 4)

The composition of claim 4, further comprising by weight:
between 0 and 1% Vitamin A;
between 0- and 5% β-carotene;
between 0 and 1% Vitamin B1;
between 0 and 1% Vitamin B2;
between 0 and 1% Vitamin B6;
between 0 and 5% lycopene;
between 0 and 20% grape seed extract;
between 0 and 20% α-lipoic acid;
between 0 and 20% propolis;
between 0 and 10% ginkgo biloba extract;
between 0 and 10% ginseng extract;
between 0 and 30% calcium carbonate;
between 0 and 30% calcium gluconate;
between 0 and 30% calcium lactate;
between 0 and 10% zinc gluconate;
between 0 and 10% zinc lactate;
between 0 and 10% ferrous gluconate fumarate;
between 0 and 1% ferrous lactate; and
between 0 and 10% ferrous fumarate.

### Claim 6 (depends on 1)

A method for improving superoxide dismutase (SOD) activity, glutathione peroxidase (GSH-PX) activity, or decreasing MDA levels in a patient, comprising administering to the patient the nutritional composition of claim 1.

### Claim 7 (depends on 2)

A method for improving superoxide dismutase (SOD) activity, glutathione peroxidase (GSH-PX) activity, or decreasing MDA levels in a patient, comprising administering to the patient the nutritional composition of claim 2.

### Claim 8 (depends on 3)

A method for improving superoxide dismutase (SOD) activity, glutathione peroxidase (GSH-PX) activity, or decreasing MDA levels in a patient, comprising administering to the patient the nutritional composition of claim 3.

### Claim 9 (depends on 4)

A method for improving superoxide dismutase (SOD) activity, glutathione peroxidase (GSH-PX) activity, or decreasing MDA levels in a patient, comprising administering to the patient the nutritional composition of claim 4.

### Claim 10 (depends on 5)

A method for improving superoxide dismutase (SOD) activity, glutathione peroxidase (GSH-PX) activity, or decreasing MDA levels in a patient, comprising administering to the patient the nutritional composition of claim 5.

### Claim 11 (depends on 1)

A method for enhancing immunity, improving antibody-producing capacity, or improving NK cell activity in a patient, comprising administering to the patient the nutritional composition of claim 1.

### Claim 12 (depends on 2)

A method for enhancing immunity, improving antibody-producing capacity, or improving NK cell activity in a patient, comprising administering to the patient the nutritional composition of claim 2.

### Claim 13 (depends on 3)

A method for enhancing immunity, improving antibody-producing capacity, or improving NK cell activity in a patient, comprising administering to the patient the nutritional composition of claim 3.

### Claim 14 (depends on 4)

A method for enhancing immunity, improving antibody-producing capacity, or improving NK cell activity in a patient, comprising administering to the patient the nutritional composition of claim 4.

### Claim 15 (depends on 5)

A method for enhancing immunity, improving antibody-producing capacity, or improving NK cell activity in a patient, comprising administering to the patient the nutritional composition of claim 5.
